Sparton Medical Systems Will Be Attending the Medical Design and Manufacturing-East Show

DeLeon Springs, FL – June 2, 2005 – Electronics Design and Manufacturing (EMS) service provider, Sparton Corporation (NYSE:SPA) will be represented by its medical group, Sparton Medical Systems (SMS), at the Medical Design and Manufacturing (MDM) East tradeshow in New York City on June 13 - 15, 2005.

Sparton Medical Systems’ exhibit will be located at booth 1983. Robert P. Kundinger, Director of Business Development for SMS and a specialist in product development for the medical device market, will be in attendance and available for additional discussion throughout the three-day conference.

About Sparton Medical Systems
Sparton Medical Systems, previously Sparton Medical Solutions, is focused on the marketing of the medical electronic design and manufacturing capabilities of Sparton Corporation. Sparton provides GMP compliant processes and facilities with ISO 13485 certification. In addition, Sparton has experience developing and manufacturing products subject to regulatory controls.

About Sparton Corporation
Sparton Corporation (NYSE:SPA) now in its 105th year, provides design engineering and electronics contract manufacturing services utilizing seven manufacturing locations encompassing nearly 855,000 sq. ft. along with several alliance partner facilities throughout North America. Sparton has also opened a manufacturing plant in Vietnam, Spartronics, which began operations in May 2005. In addition to strong core printed circuit board assembly (PCBA) and complete assembly manufacturing capabilities, Sparton offers a complete range of pre-manufacturing, post-manufacturing and engineering services including functional testing, component obsolescence services and new product introduction processes.

Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton's services described in Sparton's filings with the SEC. In particular, see the risk factors described in the Company's most recent Form 10K and Form 10Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.